Skip to menu Skip to content Skip to footer

2019

Journal Article

Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration

Tobin, Joshua W. D., Keane, Colm, Gunawardana, Jay, Mollee, Peter, Birch, Simone, Hoang, Thanh, Lee, Justina, Li, Li, Huang, Li, Murigneux, Valentine, Fink, J. Lynn, Matigian, Nicholas, Vari, Frank, Francis, Santiyagu, Kridel, Robert, Weigert, Oliver, Haebe, Sarah, Jurinovic, Vindi, Klapper, Wolfram, Steidl, Christian, Sehn, Laurie H., Law, Soi-Cheng, Wykes, Michelle N. and Gandhi, Maher K. (2019). Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration. Journal of Clinical Oncology, 37 (34), 3300-3309. doi: 10.1200/JCO.18.02365

Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration

2019

Journal Article

Renal impairment at diagnosis in myeloma: Patient characteristics, treatment, and impact on outcomes. Results trom the Australia and New Zealand myeloma and related diseases registry

Ho, P. Joy, Moore, Elizabeth M., McQuilten, Zoe K., Wellard, Cameron, Bergin, Krystal, Augustson, Bradley, Blacklock, Hilary, Harrison, Simon J., Horvath, Noemi, King, Tracy, Mollee, Peter, Quach, Hang, Reid, Christopher, Rosengarten, Brian, Walker, Patricia, Wood, Erica M. and Spencer, Andrew (2019). Renal impairment at diagnosis in myeloma: Patient characteristics, treatment, and impact on outcomes. Results trom the Australia and New Zealand myeloma and related diseases registry. Clinical Lymphoma, Myeloma and Leukemia, 19 (8), e415-e424. doi: 10.1016/j.clml.2019.05.010

Renal impairment at diagnosis in myeloma: Patient characteristics, treatment, and impact on outcomes. Results trom the Australia and New Zealand myeloma and related diseases registry

2019

Journal Article

High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy

Tate, Courtney, Burgess, Melinda, McMillan, Nigel A., Saunders, Nicholas A., Cheung, Catherine, Gill, Devinder and Mollee, Peter (2019). High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy. Leukemia and Lymphoma, 60 (10), 1-5. doi: 10.1080/10428194.2019.1581936

High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy

2019

Journal Article

The epidemiology of amyloidosis in Queensland, Australia

Wisniowski, Brendan, McLeod, Donald, Adams, Rebecca, Harvey, Yasmin, Brown, Ian, McGuire, Lloyd, Armes, Jane and Mollee, Peter (2019). The epidemiology of amyloidosis in Queensland, Australia. British Journal of Haematology, 186 (6) bjh.16000, 829-836. doi: 10.1111/bjh.16000

The epidemiology of amyloidosis in Queensland, Australia

2019

Journal Article

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

Facon, Thierry, Kumar, Shaji, Plesner, Torben, Orlowski, Robert Z., Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O'Dwyer, Michael, Perrot, Aurore, Venner, Christopher P., Weisel, Katja, Mace, Joseph R., Raje, Noopur, Attal, Michel, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Ahmadi, Tahamtan, Chiu, Christopher, Wang, Jianping, Van Rampelbergh, Rian, Uhlar, Clarissa M., Kobos, Rachel, Qi, Ming ... Mollee, Peter (2019). Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma. The New England Journal of Medicine, 380 (22), 2104-2115. doi: 10.1056/NEJMoa1817249

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

2019

Journal Article

Validation of the Boston University staging system in AL amyloidosis

Tomlinson, Ross, Matigian, Nicholas and Mollee, Peter (2019). Validation of the Boston University staging system in AL amyloidosis. Amyloid: Journal of Protein Folding Disorders, 26 (3), 1-3. doi: 10.1080/13506129.2019.1608941

Validation of the Boston University staging system in AL amyloidosis

2019

Journal Article

Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement

Chin, C. K., Tsang, E., Mediwake, H., Khair, W., Biccler, J., Hapgood, G., Mollee, P., Nizich, Z., Joske, D., Radeski, D., Cull, G., Villa, D., El-Galaly, T. C. and Cheah, C. Y. (2019). Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement. British Journal of Haematology, 184 (5), 826-828. doi: 10.1111/bjh.15173

Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement

2019

Journal Article

Paraprotein sample exchange in Australia and New Zealand - 2018

Wijeratne, Nilika, Tate, Jillian R., Toit, Stephen Du, Smith, Joel D., Soepnel, Andrew, Choy, Kay Weng, Martin, Helen, Henry, Robyn, Glegg, Kaye, Byrnes, Elizabeth, Wienholt, Louise and Mollee, Peter (2019). Paraprotein sample exchange in Australia and New Zealand - 2018. Clinical Biochemist Reviews, 40 (1), 43-54.

Paraprotein sample exchange in Australia and New Zealand - 2018

2019

Journal Article

Amyloidosis in Australia

Mollee, Peter, Gibbs, Simon and Stewart, Graeme (2019). Amyloidosis in Australia. Expert Opinion on Orphan Drugs, 7 (2), 37-39. doi: 10.1080/21678707.2019.1563539

Amyloidosis in Australia

2019

Journal Article

Report of the survey conducted by RCPAQAP on current practice for paraprotein and serum free light chain measurement and reporting: A need for harmonisation

Wijeratne, Nilika, Tate, Jillian R., Wienholt, Louise and Mollee, Peter (2019). Report of the survey conducted by RCPAQAP on current practice for paraprotein and serum free light chain measurement and reporting: A need for harmonisation. Clinical Biochemist Reviews, 40 (1), 31-42.

Report of the survey conducted by RCPAQAP on current practice for paraprotein and serum free light chain measurement and reporting: A need for harmonisation

2019

Journal Article

Proposed addendum to 2012 recommendations for standardised reporting of protein electrophoresis in Australia and New Zealand

Tate, Jillian R., Smith, Joel D., Wijeratne, Nilika and Mollee, Peter (2019). Proposed addendum to 2012 recommendations for standardised reporting of protein electrophoresis in Australia and New Zealand. Clinical Biochemist Reviews, 40 (1), 23-30.

Proposed addendum to 2012 recommendations for standardised reporting of protein electrophoresis in Australia and New Zealand

2019

Journal Article

Response to article by Caponi et al. about serum free light chains

Tate, Jillian R., Hawley, Carmel and Mollee, Peter (2019). Response to article by Caponi et al. about serum free light chains. Clinical Chemistry and Laboratory Medicine, 57 (2), e1-e2. doi: 10.1515/cclm-2018-0994

Response to article by Caponi et al. about serum free light chains

2019

Journal Article

Correction to: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group (Nature Reviews Nephrology, (2019), 15, 1, (45-59), 10.1038/s41581-018-0077-4)

Leung, Nelson, Bridoux, Frank, Batuman, Vecihi, Chaidos, Aristeidis, Cockwell, Paul, D’Agati, Vivette D., Dispenzieri, Angela, Fervenza, Fernando C., Fermand, Jean- Paul, Gibbs, Simon, Gillmore, Julian D., Herrera, Guillermo A., Jaccard, Arnaud, Jevremovic, Dragan, Kastritis, Efstathios, Kukreti, Vishal, Kyle, Robert A., Lachmann, Helen J., Larsen, Christopher P., Ludwig, Heinz, Markowitz, Glen S., Merlini, Giampaolo, Mollee, Peter, Picken, Maria M., Rajkumar, Vincent S., Royal, Virginie, Sanders, Paul W., Sethi, Sanjeev, Venner, Christopher P. ... Nasr, Samih H. (2019). Correction to: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group (Nature Reviews Nephrology, (2019), 15, 1, (45-59), 10.1038/s41581-018-0077-4). Nature Reviews Nephrology, 15 (2), 121-121. doi: 10.1038/s41581-018-0102-7

Correction to: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group (Nature Reviews Nephrology, (2019), 15, 1, (45-59), 10.1038/s41581-018-0077-4)

2019

Journal Article

PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia

Enya Chen, Yu-Chen, Burgess, Melinda, Mapp, Sally, Mollee, Peter, Gill, Devinder, Blumenthal, Antje and Saunders, Nicholas A. (2019). PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia. Leukemia, 34 (2), 451-461. doi: 10.1038/s41375-019-0556-z

PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia

2019

Journal Article

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

Leung, Nelson, Bridoux, Frank, Batuman, Vecihi, Chaidos, Aristeidis, Cockwell, Paul, D’Agati, Vivette D., Dispenzieri, Angela, Fervenza, Fernando C., Fermand, Jean-Paul, Gibbs, Simon, Gillmore, Julian D., Herrera, Guillermo A., Jaccard, Arnaud, Jevremovic, Dragan, Kastritis, Efstathios, Kukreti, Vishal, Kyle, Robert A., Lachmann, Helen J., Larsen, Christopher P., Ludwig, Heinz, Markowitz, Glen S., Merlini, Giampaolo, Mollee, Peter, Picken, Maria M., Rajkumar, Vincent S., Royal, Virginie, Sanders, Paul W., Sethi, Sanjeev, Venner, Christopher P. ... Nasr, Samih H. (2019). The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nature Reviews Nephrology, 15 (1), 45-59. doi: 10.1038/s41581-018-0077-4

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

2019

Journal Article

Bilateral amyloidoma of the trigeminal nerve causing a progressive trigeminal neuropathy: An unusual presentation of localised AL amyloidosis involving the peripheral nervous system

Lyons, Alexandra, Schweitzer, Daniel, Robertson, Thomas, Mollee, Peter, Tsahtsarlis, Antonio, Mitchell, Roger and Wong, David (2019). Bilateral amyloidoma of the trigeminal nerve causing a progressive trigeminal neuropathy: An unusual presentation of localised AL amyloidosis involving the peripheral nervous system. Neurology and Neurosurgery, 2 (2). doi: 10.15761/nns.1000124

Bilateral amyloidoma of the trigeminal nerve causing a progressive trigeminal neuropathy: An unusual presentation of localised AL amyloidosis involving the peripheral nervous system

2018

Journal Article

A Comparison of High-Dose Cytarabine during Induction Versus Consolidation Therapy in Newly Diagnosed AML

Schwarer, Anthony P., Butler, Jason, Jackson, Kathryn, Beligaswatte, Ashanka, Martin, Louisa, Kennedy, Glen, Daniela, Zantomio, Lewis, Ian, Hiwase, Devendra, Wight, Joel, He, Simon, Grigg, Andrew, Morris, Kirk, Mollee, Peter and Marlton, Paula (2018). A Comparison of High-Dose Cytarabine during Induction Versus Consolidation Therapy in Newly Diagnosed AML. HemaSphere, 2 (6) e158, 1-8. doi: 10.1097/HS9.0000000000000158

A Comparison of High-Dose Cytarabine during Induction Versus Consolidation Therapy in Newly Diagnosed AML

2018

Journal Article

Response to Letter to the Editor about immunochemical measurement of urine free light chains

Tate, Jillian R. and Mollee, Peter (2018). Response to Letter to the Editor about immunochemical measurement of urine free light chains. Clinical Chemistry and Laboratory Medicine, 57 (2), e3-e4. doi: 10.1515/cclm-2018-1082

Response to Letter to the Editor about immunochemical measurement of urine free light chains

2018

Journal Article

Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: a retrospective analysis based on the prospective, international, multicenter PTLD-1 trials

Zimmermann, Heiner, Babel, Nina, Dierickx, Daan, Morschhauser, Franck, Mollee, Peter, Zaucha, Jan M., Dreyling, Martin H., Dührsen, Ulrich, Reinke, Petra, Verhoef, Gregor, Subklewe, Marion, Hüttmann, Andreas, Tousseyn, Thomas, Bachy, Emmanuel, Hauser, Ingeborg A., Tarella, Corrado, Van Den Neste, Eric, Gheysens, Olivier, Anagnostopoulos, Ioannis, Leblond, Veronique, Riess, Hanno, Choquet, Sylvain and Trappe, Ralf U. (2018). Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: a retrospective analysis based on the prospective, international, multicenter PTLD-1 trials. Transplantation, 102 (11), 1914-1923. doi: 10.1097/TP.0000000000002269

Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: a retrospective analysis based on the prospective, international, multicenter PTLD-1 trials

2018

Journal Article

Pomalidomide – author reply

Scott, Ashleigh P. and Mollee, Peter (2018). Pomalidomide – author reply. Leukemia and Lymphoma, 60 (4), 1-1. doi: 10.1080/10428194.2018.1516884

Pomalidomide – author reply